Position in ARGX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$248,493,121
-$51,616,705 QoQ
Shares Held
340,285
-4.6% QoQ
Ownership
0.547%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 70.65577383663694.ToString("F0")%
Shared 0.ToString("F0")%
None 29.344226163363064.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SANDS CAPITAL MANAGEMENT, LLC holds $315,837,587 across 2 Biotechnology names. ARGX ranks #1 (78.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
340,285 | $248,493,121 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
3,214,533 | $67,344,466 |
All Filings in ARGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $248,493,121 | 340,285 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $300,109,826 | 356,870 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,261,935 | 16,625 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||